<![CDATA[
Why Lyme Disease During Pregnancy Demands Attention
Pregnancy is a time when the health of both mother and developing child is paramount. For women who have been diagnosed with Lyme disease — or who suspect they may have been exposed — the intersection of tick-borne infection and pregnancy raises serious questions about risks, testing, and safe treatment options.
The topic remains underresearched compared to other gestational infections, and the medical literature contains conflicting reports about the degree of risk. What is clear, however, is that active Borrelia infection during pregnancy warrants careful attention, proactive testing, and appropriate treatment — ideally before conception when possible.
At St. George Hospital in Bad Aibling, Germany, Dr. Julian Douwes and our infectious disease team have extensive experience advising women with Lyme disease who are planning pregnancy or who discover they are pregnant during treatment. Our approach prioritizes both maternal health and fetal safety.
Can Lyme Disease Be Transmitted During Pregnancy?
The question of gestational (vertical) transmission of Borrelia burgdorferi — from mother to fetus through the placenta — has been investigated since the 1980s. The evidence, while not entirely conclusive, suggests that transplacental transmission is biologically plausible and has been documented in individual cases.
What the Evidence Shows
Several case reports have identified Borrelia spirochetes in placental tissue, fetal organs, and cord blood from pregnant women with active Lyme disease. A study published in Annals of Internal Medicine documented Borrelia in fetal tissue from adverse pregnancy outcomes in women with untreated Lyme disease.
However, large epidemiological studies have not consistently demonstrated a strong association between maternal Lyme disease and adverse pregnancy outcomes when the infection is appropriately treated. This suggests that the risk is primarily associated with untreated or inadequately treated infection.
Potential Risks of Untreated Lyme Disease in Pregnancy
Case reports and small series have associated untreated gestational Lyme disease with:
- Spontaneous miscarriage
- Preterm birth
- Stillbirth
- Congenital cardiac abnormalities (rare, case-reported)
- Neonatal rash and other congenital symptoms (rare)
It is essential to emphasize that these adverse outcomes have been reported primarily in cases of untreated infection. When Lyme disease is identified and treated during pregnancy, the risk of adverse outcomes appears to be substantially reduced.
The Reassuring Perspective
Large population-based studies have not found a statistically significant increase in birth defects or adverse pregnancy outcomes attributable to Lyme disease when treatment is administered. This is reassuring but should not lead to complacency — the prudent approach is to identify and treat active infection, particularly before or early in pregnancy.
Testing for Lyme Disease Before and During Pregnancy
Pre-Conception Testing
For women with a history of tick exposure, prior Lyme disease diagnosis, or symptoms suggestive of tick-borne illness, pre-conception testing is strongly recommended. Identifying and treating active infection before pregnancy offers several advantages:
- A wider range of treatment options is available (some medications used in Lyme treatment are contraindicated in pregnancy)
- Aggressive treatment protocols — including hyperthermia therapy and certain combination antibiotic regimens — can be employed without fetal risk considerations
- Co-infections can be comprehensively addressed
- Immune function can be optimized before the physiological immunosuppression of pregnancy begins
Testing During Pregnancy
For women who develop symptoms suggestive of Lyme disease during pregnancy (erythema migrans rash, flu-like symptoms after tick exposure, unexplained joint pain, or fatigue exceeding normal pregnancy fatigue), prompt testing is essential.
The diagnostic approach during pregnancy follows the same principles as standard Lyme testing, though interpretation requires awareness of pregnancy-related immune changes. Standard serology (ELISA and Western blot), cellular immune testing (ELISpot/LTT), and co-infection screening are all safe during pregnancy. Our diagnostic laboratory at St. George Hospital provides comprehensive testing with results interpreted by physicians experienced in both Lyme disease and gestational medicine.
The Role of Immune Changes in Pregnancy
Pregnancy naturally shifts the immune system toward a Th2-dominant state — suppressing certain cell-mediated immune responses while enhancing antibody production. This physiological immunomodulation is essential for tolerating the genetically foreign fetus but may have implications for Lyme disease:
- Reduced cell-mediated immunity may allow Borrelia to proliferate more readily
- Symptoms may flare during pregnancy due to altered immune surveillance
- Some serological tests may behave differently during pregnancy
These factors underscore the importance of pre-conception evaluation and treatment when possible.
Safe Treatment Options During Pregnancy
When Lyme disease treatment is necessary during pregnancy, the choice of medications must balance efficacy against potential fetal toxicity. The following framework guides treatment decisions:
Pregnancy-Safe Antibiotics for Lyme Disease
Amoxicillin
Amoxicillin is considered the first-line treatment for Lyme disease during pregnancy. It is classified as FDA pregnancy category B, has decades of safety data in pregnant women, and has good activity against Borrelia burgdorferi. Typical dosing for gestational Lyme disease is 500 mg three times daily, with treatment duration determined by clinical response and stage of disease.
Ceftriaxone
For disseminated Lyme disease or neurological involvement during pregnancy, intravenous ceftriaxone may be necessary. Ceftriaxone is pregnancy category B and can be administered safely, though it should be used with caution near delivery due to theoretical risk of neonatal hyperbilirubinemia.
Cefuroxime
An oral cephalosporin alternative with activity against Borrelia. Pregnancy category B and well-tolerated.
Medications to Avoid During Pregnancy
Doxycycline
Tetracycline-class antibiotics, including doxycycline — the most commonly prescribed Lyme disease medication — are contraindicated during pregnancy and breastfeeding. These drugs can cause permanent dental staining and bone growth abnormalities in the developing fetus, particularly during the second and third trimesters.
Metronidazole (First Trimester)
Sometimes used for Lyme cystic forms, metronidazole should be avoided in the first trimester due to potential teratogenicity, though it may be used cautiously in later pregnancy when benefits outweigh risks.
Supportive Therapies During Pregnancy
Certain supportive therapies that are safely used during pregnancy can complement antibiotic treatment:
- Probiotic supplementation: To mitigate antibiotic-associated disruption of maternal and neonatal microbiome
- Targeted nutritional support: Immune-supportive nutrients (vitamin D, zinc, vitamin C) at pregnancy-safe dosages
- Gentle detoxification support: Adequate hydration, safe-for-pregnancy liver support
Our Pre-Conception Protocol at St. George Hospital
For women with known or suspected Lyme disease who are planning pregnancy, Dr. Julian Douwes has developed a structured pre-conception protocol:
- Comprehensive diagnostic evaluation: Full Lyme disease testing including serology, ELISpot/LTT, CD57, and co-infection screening
- Aggressive treatment if indicated: Taking advantage of the full treatment toolkit (including doxycycline, hyperthermia, and combination regimens) available before pregnancy
- Co-infection clearance: Treatment of Babesia, Bartonella, and other co-infections that may be difficult to address during pregnancy
- Immune optimization: Immune-supportive therapies and nutritional optimization to establish robust immune function before conception
- Treatment response confirmation: Post-treatment monitoring with repeat testing and symptom assessment to confirm adequate treatment response
- Conception timing: Guidance on appropriate waiting period after treatment completion before attempting conception
This structured approach offers the best opportunity to enter pregnancy with the infection adequately addressed and the immune system optimally prepared.
Breastfeeding Considerations
For women with Lyme disease who are breastfeeding or planning to breastfeed, several considerations apply:
Is Borrelia Transmitted Through Breast Milk?
There is no confirmed evidence that Borrelia burgdorferi is transmitted through breast milk. While Borrelia DNA has been detected in breast milk in isolated case reports, the clinical significance of this finding is uncertain, and documented cases of transmission through breastfeeding have not been established.
Medication Safety During Breastfeeding
- Amoxicillin: Compatible with breastfeeding; only trace amounts enter breast milk
- Cephalosporins: Generally compatible with breastfeeding
- Doxycycline: Short courses (up to 21 days) are now considered acceptable during breastfeeding by the American Academy of Pediatrics, though longer courses should be discussed with a physician
Balancing Treatment and Breastfeeding
The decision to treat Lyme disease during breastfeeding should weigh the importance of treating the mother’s infection against the minimal risk to the infant from pregnancy-compatible antibiotics. In most cases, effective treatment can be provided without interrupting breastfeeding.
Frequently Asked Questions About Lyme Disease and Pregnancy
Should I get tested for Lyme disease before getting pregnant?
If you live in a tick-endemic area, have a history of tick bites, or have experienced symptoms consistent with Lyme disease, pre-conception testing is strongly recommended. Identifying and treating infection before pregnancy allows for the most comprehensive treatment approach with the least risk to the developing fetus. At St. George Hospital, we offer thorough pre-conception evaluation for women concerned about Lyme disease.
I was treated for Lyme disease two years ago. Is it safe to get pregnant?
If your treatment was successful — evidenced by symptom resolution, normalized inflammatory markers, and stable or improving CD57 counts — pregnancy after adequate treatment is generally considered safe. However, a pre-conception reassessment to confirm that the infection remains in remission is prudent, particularly for women who had late-stage or chronic Lyme disease.
Can Lyme disease cause infertility?
The relationship between Lyme disease and fertility is not well-studied. Some clinicians have observed that chronic Lyme disease — with its associated hormonal disruption, inflammatory burden, and immune dysfunction — may contribute to difficulty conceiving. Chronic illness in general can affect fertility through multiple mechanisms. Addressing underlying infection and optimizing overall health may improve fertility outcomes, though direct causation has not been established.
What if I discover I have Lyme disease during pregnancy?
If Lyme disease is diagnosed during pregnancy, prompt treatment with pregnancy-safe antibiotics (amoxicillin or cephalosporins) is recommended. The risk of untreated infection to the pregnancy is considered greater than the risk of appropriate antibiotic therapy. Your treating physician should coordinate with your obstetrician to ensure an integrated approach to care. Do not delay treatment out of concern about medication safety — the pregnancy-compatible options have excellent safety profiles.
Planning for a Healthy Pregnancy After Lyme Disease
If you are living with Lyme disease and planning a family, proactive preparation can make a meaningful difference. At St. George Hospital, we provide comprehensive pre-conception evaluation, treatment, and monitoring to help you enter pregnancy with confidence.
Contact our international patient team to discuss your situation:
- Phone: +49 (0)8061 398-0
- Email: info@clinicum-stgeorg.de
- Online: Request a consultation
This article is for informational purposes only and does not constitute medical advice. Lyme disease management during pregnancy requires qualified medical supervision. Individual circumstances vary — always consult your physician for personalized guidance.
]]>